Abstract: This invention relates to a personal feature diagnostic apparatus on the basis of an oscillometric arterial pressure measurement comprising a pressure detection sensor unit for detecting a cuff pressure including an effect of pulse wave; a pulse wave extraction unit for extracting pulse wave signals of the artery from the cuff pressure detected in the pressure detection sensor unit; a pulse wave amplitude detection unit for dividing pulse wave signals extracted from the pulse wave extraction unit into a plurality of window sections and detecting a minimum amplitude pulse in each window section; and a personal feature diagnostic unit for diagnosing personal feature by using the minimum amplitude pulse in each window section detected by the pulse wave amplitude detection unit.
Type:
Application
Filed:
April 20, 2011
Publication date:
November 29, 2012
Applicant:
Industry-Academic Cooperation Foundation, Chosun University
Abstract: The present invention provides a tumor cell-killing peptide and a pharmaceutical composition for treating a cancer. The tumor cell-killing peptide of the present invention selectively homes into tumor cells so that it can induce the death of tumor cells effectively while minimizing the harming of normal cell.
Type:
Application
Filed:
August 16, 2010
Publication date:
June 28, 2012
Applicant:
Industry-Academic Cooperation Foundation Chosun University
Abstract: The present invention relates to a method for expressing each of peptide antibiotics P5 3 and Anal3 35 having amphiphilicity and showing antibacterial, antifungal and anticancer activities 61, 63, 65, 67, 69, 71, on the microbial surface, using a vector containing outer membrane protein genes (pgsBCA) that are derived from Bacillus sp. strains and involved in the synthesis of poly-gamma-glutamate. Moreover, the present invention relates to lactic acid-forming bacteria having each of the peptide antibiotics P5 15 and Anal3 43 expressed on their surface, and the use thereof. According to the present invention, the peptide antibiotics can be expressed on the surface of various microorganisms transformed with the surface expression vectors. The inventive method for the surface expression of the peptide antibiotics allows the peptide antibiotics to be mass-produced without a purification process. Thus, the inventive method has very high industrial applicability.
Type:
Grant
Filed:
January 11, 2007
Date of Patent:
December 20, 2011
Assignees:
Bioleaders Corporation, Korea Research Institute of Bioscience and Biotechnology, Chosun University
Inventors:
Moon-Hee Sung, Seung-Pyo Hong, Jong-Su Lee, Chang-Min Jung, Kyung-Soo Hahm, Dong-Gun Lee, Yoon Kyung Park, Chul-Joong Kim, Ha-Ryoung Poo
Abstract: A fingerprint information storage apparatus includes a fingerprint information generating unit that extracts minutiae information from an authenticated user's fingerprint image and generates fingerprint information by inserting chaff minutiae information into the extracted minutiae information, a fingerprint information distributing unit that classifies the fingerprint information according to the extent that minutiae are distributed relative to the center of the fingerprint and distributively outputs the fingerprint information classified according to the distribution, and a first fingerprint information storage unit and a second fingerprint information storage unit that store the fingerprint information and distributively output according to the distribution, wherein the authenticated user's fingerprint information registered in the first fingerprint information storage unit is partially aligned and input fingerprint information is converted based on the information so that the converted input fingerprint i
Type:
Application
Filed:
March 24, 2009
Publication date:
April 15, 2010
Applicant:
Industry-Academic Cooperation Foundation, Chosun University
Inventors:
Sung Bum Pan, Sung Jin Lim, Yong Wha Chung, Han Na Choi
Abstract: A magnetic flux coupling-type superconducting current limiter is capable of protecting lines more effectively by winding reactors of a primary coil and a secondary coil in series in the structure where the primary coil and the secondary coils are wound in parallel in the conventional magnetic flux-lock type current limiter to increase a linked flux generated from an iron core. An electric conducting current which rapidly increases when a fault occurs is divided into the secondary coil and a superconducting coil to decrease a load on the superconducting element and it is opened more rapidly than the existing superconducting current limiter during a quench time such that it better limits a fault current.
Type:
Grant
Filed:
March 30, 2007
Date of Patent:
March 16, 2010
Assignee:
Industry-Academic Cooperation Foundation, Chosun University
Abstract: A magnetic flux coupling-type superconducting current limiter is capable of protecting lines more effectively by winding reactors of a primary coil and a secondary coil in series in the structure where the primary coil and the secondary coils are wound in parallel in the conventional magnetic flux-lock type current limiter to increase a linked flux generated from an iron core. An electric conducting current which rapidly increases when a fault occurs is divided into the secondary coil and a superconducting coil to decrease a load on the superconducting element and it is opened more rapidly than the existing superconducting current limiter during a quench time such that it better limits a fault current.
Type:
Application
Filed:
March 30, 2007
Publication date:
November 8, 2007
Applicant:
Industry-Academic Cooperation Foundation, Chosun University
Abstract: The present invention relates to a method for expressing each of peptide antibiotics P5 3 and Anal3 35 having amphiphilicity and showing antibacterial, antifungal and anticancer activities 61, 63, 65, 67, 69, 71, on the microbial surface, using a vector containing outer membrane protein genes (pgsBCA) that are derived from Bacillus sp. strains and involved in the synthesis of poly-gamma-glutamate. Moreover, the present invention relates to lactic acid-forming bacteria having each of the peptide antibiotics P5 15 and Anal3 43 expressed on their surface, and the use thereof. According to the present invention, the peptide antibiotics can be expressed on the surface of various microorganisms transformed with the surface expression vectors. The inventive method for the surface expression of the peptide antibiotics allows the peptide antibiotics to be mass-produced without a purification process. Thus, the inventive method has very high industrial applicability.
Type:
Application
Filed:
February 27, 2004
Publication date:
September 1, 2005
Applicants:
Bioleaders Corporation, Korea Research Institute of Bioscience and Biotechnology, Chosun University
Inventors:
Moon-Hee Sung, Seung-Pyo Hong, Jong-Su Lee, Chang-Min Jung, Kyung-Soo Hahm, Dong-Gun Lee, Yoon Park, Chul-Joong Kim, Ha-Ryoung Poo
Abstract: The present invention relates to novel peptides with increased + charge and hydrophobicity by substituting one or more amino acids of CA-MA peptide in which cecropin A (CA) and magainin 2(MA) were conjugated and pharmaceutical compositions containing thereof. More precisely, the present invention relates to synthetic peptides prepared by substituting one or more amino acids of CA-MA peptide represented by the SEQ. ID. NO: 1 with amino acids having + charge and hydrophobicity and anti-bacterial, anti-fungal and anticancer compositions containing thereof. The synthetic peptides of the present invention have no cytotoxicity but have excellent anti-bacterial, anti-fungal and anticancer activity, leading in an effective use thereof as a safe anticancer agent and antibiotics.
Type:
Grant
Filed:
February 22, 2002
Date of Patent:
October 5, 2004
Assignee:
Chosun University
Inventors:
Kyung-Soo Hahm, Dong Gun Lee, YoonKyung Park